Orion Corporation B
Orion Corporation B
1.59 %
35.11 EUR
0.55
Quote
35.11
High
35.11
Change
1.59 %
Low
34.49
Updated
18/03/2019
Open
34.49
News about Orion Corporation B
Factsheet for Orion Corporation B
Company Profile
Description
Orion Oyj is a specialty and generic drug manufacturing company. Orion maintains two segments, which are Pharmaceuticals business and Diagnostics business. The Pharmaceuticals business develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients. The Diagnostics business develops, manufactures, and markets diagnostic tests. Most of the company's sales are generated by the pharmaceuticals segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Key Stats
Website: http://www.orion.fi
Headquarter country: Finland
Employees: 3,514
Market Cap (at close 18/03/2019): EUR 5B
Fiscal Year Ends: December
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 20.90 19.90 24.70 21.50 17.70
Forward Price/Earnings 21.80 19.40
Price/Free Cash Flow 25.70 25.00 29.40 21.50 14.40
Return on Assets 30.00 21.30 23.60 20.30 21.30
Return on Equity 45.50 34.20 40.30 37.50 41.10
Return on Invested Capital 38.00 28.20 32.10 27.70 28.30
Dividend


Dividend/Share:1.50
Ex. Dividend Date:31/12/2018
Trailing Dividend Yield:4.13
Payout Ratio:103.57
Date Currency Amount
31/03/2018 EUR 1.45
31/03/2017 EUR 1.35
31/03/2016 EUR 1.30
31/03/2015 EUR 1.30
31/03/2014 EUR 1.25
31/03/2013 EUR 1.30
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 977.40 1,084.70 1,073.50 1,015.60 1,015.30
Gross Profit 0.59 0.64 0.65 0.61 0.61
Gross Margin % 60.32% 59.37% 60.72% 60.04% 60.44%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 295.00 333.00 356.00 309.00 313.00
Net income 330.00 226.00 249.00 208.00 211.00
Basic Earnings Per Share 2.35 1.61 1.77 1.48 1.50
Operating Income 0.25 0.29 0.29 0.27 0.27
Operating Margin % 25.68% 26.99% 27.21% 26.36% 26.75%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 231.00 228.00 249.00 255.00 297.00
Capital Expenditures -67.00 -77.00 -48.00 -43.00 -56.00
Free Cash Flow 164.00 152.00 201.00 212.00 240.00
Balance Sheet

Assets 31/12/2018 31/12/2017 31/12/2016 31/12/2015 31/12/2014
Current Assets 728.20 620.70 691.50 674.10 652.40 629.90
Long Term Assets 418.50 434.70 371.50 373.30 349.10 349.20
Total Assets 1,146.70 1,055.50 1,062.90 1,047.40 1,001.50 979.00
Liabilities 31/12/2018 31/12/2017 31/12/2016 31/12/2015 31/12/2014
Total Current Liabilities 313.80 179.70 230.60 233.30 214.80 197.50
Long Term Liabilities 196.10 190.80 219.20
Total Liabilities 375.80 421.50 452.50
Equity 31/12/2018 31/12/2017 31/12/2016 31/12/2015 31/12/2014
Retained Earnings 678.00 584.60 546.60 495.30 416.30 419.60
Treasury Stock
Total Stockholder Equity 773.10 679.70 641.10 594.90 514.90 513.90
Net Tangible Assets 709.50 626.80 587.20 537.20 450.90 443.10